Canadian Society of Allergy and Clinical Immunology
Société canadienne d'allergie et d'immunologie clinique
Disclaimer Décharge de responsabilité
What's New
Joint statement on FDA investigation of Singulair from the AAAAI and ACAAI 17kb posted 21/04/08
www.aaaai.org www.merckfrosst.ca www.fda.gov/cder/drug/early_comm/montelukast.htm
Epinephrine Auto-Injectors
Employment Opportunities
Bill 3- An Act to Protect Anaphylactic Students
Urgent Drug (Class II) Recall Pre-Pen
Urgent Rappel (Catégorie II) de produit : Pre-Pen 54kb
17kb